CADENT CAPITAL ADVISORS, LLC – Bristol-Myers Squibb Company Transaction History
CADENT CAPITAL ADVISORS, LLC portfolio value:
$234,000
portfolio value
CADENT CAPITAL ADVISORS, LLC quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.70% | 23 shares | -18K | $71.09 | 3.29K |
| Q2 2022 | share | Decrease | -1.92% | -64 shares | 9K | $77 | 3.26K |
| Q1 2022 | share | Increase | 0.00% | 3.33K shares | 243K | $73.03 | 3.33K |
| Q3 2021 | share | Decrease | -100.00% | -2.99K shares | -200K | $59.17 | 0 |
| Q2 2021 | share | Decrease | -9.81% | -326 shares | -10K | $65.79 | 2.99K |
| Q1 2021 | share | Increase | 0.00% | 3.32K shares | 210K | $62.15 | 3.32K |